 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI NASDAQ:ANIP today announced that it has acquired the new drug applications NDAs for OXISTAT Lotion, VEREGEN Ointment, and Pandel Cream and the abbreviated new drug application ANDA for ApexiCon E Cream from Sandoz Inc. Pandel Cream will be transitioned later upon receiving the requisite approvals. Collectively, these products generated net revenues of 13.2 million in 2020. The acquisition was funded through borr 